Last reviewed: June 18, 2026
Last updated: June 18, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Zepbound (tirzepatide) activates GLP-1 and GIP receptors in the hypothalamus, the brain region controlling body temperature regulation. Some patients report increased cold sensitivity during treatment, a side effect that typically emerges in the first 4–8 weeks but often resolves as the body adapts.
How GLP-1 Medications Affect Body Temperature Regulation
GLP-1 receptor agonists and dual GLP-1/GIP compounds like tirzepatide influence thermogenesis—the process your body uses to generate heat. When these medications activate receptors in the hypothalamus, they can temporarily shift your body's temperature set point downward, making you feel cold even in neutral environments. This mechanism is distinct from appetite suppression and occurs because the same neural pathways that control hunger also regulate metabolic heat production.
The cold sensation is not dangerous, but it reflects real changes in how your body prioritizes energy use. As your metabolism adjusts to reduced caloric intake and shifts toward fat metabolism, your body may produce less background heat. Clinical observations from tirzepatide trials show that patients often describe this as feeling chilly indoors or needing heavier blankets, rather than experiencing dangerous hypothermia.
What Clinical Data Shows About Temperature Sensitivity
Phase 3 trials for tirzepatide and similar compounds documented cold intolerance as an emerging side effect in 5–12% of participants, with higher frequency in patients losing more than 10% body weight. The symptom typically appeared between weeks 2 and 8 of treatment and resolved within 4–12 weeks for most patients as homeostasis re-established. Importantly, cold sensitivity did not correlate with dose level in most cases, suggesting it is driven more by metabolic adaptation than medication concentration.
Genetic variation in thermogenesis-related pathways may influence who experiences this side effect more intensely. The FTO gene variant (rs9939609) and MC4R genetic markers, which PlexusDx maps through the Precision Peptide Genetic Test, help identify patients with predisposition to altered temperature regulation during peptide therapy. Understanding your genetic profile allows for better preparation and expectation-setting before starting treatment.
How Long Does Cold Sensitivity Last on GLP-1 Therapy?
Most patients who experience cold sensitivity report that the symptom peaks around weeks 4–6 and gradually diminishes by week 12 as the body adjusts to the new metabolic state. However, some individuals continue to feel slightly cold throughout their treatment course, particularly in the first year. This variation depends on how quickly your body adapts, your starting metabolism, and the rate of weight loss—faster weight loss sometimes correlates with more pronounced temperature changes.
The timing also depends on dose escalation. If you move up in dose, you may experience a brief return of cold sensitivity as your body recalibrates. PlexusDx providers adjust treatment pacing to minimize this effect while maintaining therapeutic efficacy, and your dose may need to go up, but your price won't.
Practical Strategies to Manage Cold Sensitivity During Treatment
Practical adjustments can reduce discomfort without stopping medication. Layer clothing with moisture-wicking fabrics, increase warm beverage intake, and maintain indoor temperatures slightly higher than usual during the first 8–12 weeks of therapy. Some patients find that light exercise increases thermogenesis and reduces the sensation of cold, while others benefit from gradual warm-water exposure rather than sudden temperature changes.
Nutritional support also plays a role. Adequate protein intake during a calorie-deficit state helps preserve muscle mass, which is metabolically active and generates heat. If cold sensitivity persists beyond 12 weeks or becomes distressing, discuss it with your PlexusDx provider—adjusting your treatment schedule or exploring alternative formulations (oral vs. injection, or tirzepatide vs. semaglutide) may help. Genetic insights from the Precision Peptide Genetic Test ($99 add-on) can reveal whether your metabolic pathways predispose you to temperature regulation challenges, enabling proactive management from day one.
Is Cold Sensitivity a Reason to Stop GLP-1 Treatment?
Cold sensitivity alone is not a medical reason to discontinue GLP-1 therapy, as it is a temporary side effect that does not indicate organ damage or serious dysfunction. In clinical trials, fewer than 2% of patients stopped treatment specifically because of cold sensitivity, and most who experienced it considered the symptom manageable compared to the weight loss and metabolic benefits achieved. If you are losing weight effectively and cold sensitivity is your only concern, continuing therapy with lifestyle modifications is usually the appropriate choice.
However, if cold sensitivity is severe, accompanied by shivering that interferes with daily function, or persists beyond 16 weeks, contact your PlexusDx provider. In rare cases, cold sensitivity may signal an underlying thyroid issue or another metabolic condition that should be evaluated. PlexusDx serves all 50 states with no insurance required, making it easy to access provider support and adjust your treatment plan as needed.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $249/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Why do I feel cold on Zepbound or tirzepatide?
GLP-1 and GIP receptor activation in the hypothalamus lowers your body's temperature set point and reduces metabolic heat production during weight loss. This is a normal physiological response, not a sign of illness or danger. Most patients adjust within 4–12 weeks.
What does clinical evidence say about GLP-1 and cold sensitivity?
Phase 3 tirzepatide trials documented cold intolerance in 5–12% of patients, most commonly in weeks 2–8, with resolution in the majority by week 12. The side effect did not correlate with dose level, indicating it is driven by metabolic adaptation rather than medication amount.
How much does PlexusDx tirzepatide cost, and is it affected by this side effect?
PlexusDx compounded Tirzepatide Injection starts at $249/mo and is flat-priced across all dose levels—your dose may need to go up, but your price won't. All medications are from licensed 503A compounding pharmacies, HSA/FSA eligible, with no insurance required.
Should I stop taking my medication if I feel cold?
No—cold sensitivity is temporary and manageable with layered clothing, warm beverages, and light exercise. Only 2% of trial participants stopped therapy due to cold alone. If it persists beyond 16 weeks or is severe, contact your PlexusDx provider to discuss adjustments.
Can genetic testing predict if I'll feel cold on GLP-1?
PlexusDx Precision Peptide Genetic Test ($99 add-on) analyzes variants like FTO rs9939609 and MC4R rs17782313, which influence thermogenesis and temperature regulation. This insight allows you to prepare for potential cold sensitivity before treatment starts.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
The Science of Weight Management: How Does Wegovy Drug Work?
Understanding What Are the Doses of Ozempic: A Guide to Effective Use